Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 29, 2015 1:23 PM ET

Biotechnology

Company Overview of Axovant Sciences Ltd.

Executive Profile

Gregory M. Weinhoff M.D., MBA

Chief Financial Officer, Axovant Sciences Ltd.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.

See Board Relationships
44--

Background

Dr. Gregory M. Weinhoff, also known as Greg, M.D., MBA, has been Chief Financial Officer of Axovant Sciences Ltd. since August 12, 2015. He is also Principal Financial Officer of Axovant Sciences Ltd. He joined CHL Healthcare Partners in 2001, and was active in the biotechnology, molecular diagnostics, medical device, and healthcare services sectors. Dr. Weinhoff was employed by Collinson Howe Venture Partners from 2001 to August 2015. From 2000 to 2001, he served as ...

Corporate Headquarters

Clarendon House
Hamilton, -- HM 11

Bermuda

Phone: 441-295-5950
Fax: --

Board Members Memberships

Director
Director
Executive Chairman
Director

Education

MBA
Harvard Business School
BA
Harvard College
MD
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Axovant Sciences Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.